Oral Solid Dosage Contract Manufacturing Market Report 2026

Oral Solid Dosage Contract Manufacturing Market Overview

• Oral Solid Dosage Contract Manufacturing market size has reached to $42.39 billion in 2025 • Expected to grow to $59.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Increasing Demand For Generic Drugs Fuels Growth In The Oral Solid Dosage Contract Manufacturing Market • Market Trend: Companies In Oral Solid Dosage Contract Manufacturing Market Focus On Innovative Solutions To Stay Competitive • Asia-Pacific was the largest region in 2025.

What Is Covered Under Oral Solid Dosage Contract Manufacturing Market?

Oral solid dosage contract manufacturing refers to outsourcing the production of oral solid dosage forms of pharmaceuticals to third-party manufacturers. This outsourcing strategy allows pharmaceutical companies to focus on their core activities, such as research, development, and marketing, while leveraging the expertise and capabilities of contract manufacturing organizations (CMO) to efficiently produce high-quality oral solid dosage pharmaceuticals. The main product types of oral solid dosage contract manufacturing are tablets, capsules, powders, granules and other product types. A tablet is a small, solid mass of medicine containing an active drug and excipients. The services are drug product development, fill finish product manufacturing, API manufacturing, packaging and labelling and other applications. The therapeutic areas are oncology, cardiovascular diseases, metabolic disorders, neurological disorders, infectious diseases, gastrointestinal diseases and other therapeutic areas. The end users are large size companies and medium and small size companies.

What Is The Oral Solid Dosage Contract Manufacturing Market Growth Forecast?

The oral solid dosage contract manufacturing market size is expected to see strong growth in the next few years. It will grow to $59.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growing demand for scalable pharmaceutical manufacturing solutions, increasing pipeline of oral solid dosage drugs, rising investment in advanced manufacturing technologies, expansion of pharmaceutical outsourcing in emerging markets, increasing need for flexible and rapid production capabilities. Major trends in the forecast period include rising outsourcing of oral solid dosage manufacturing by pharmaceutical companies, increasing demand for high-volume and cost-efficient tablet and capsule production, growing adoption of modified and controlled release oral solid dosage forms, rising focus on regulatory compliance and quality assurance in contract manufacturing, increasing preference for end-to-end manufacturing and packaging services.

Global Oral Solid Dosage Contract Manufacturing Market Segmentation

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types 2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications 3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas 4) By End User: Large Size Companies, Medium And Small Size Companies Subsegments: 1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets 2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules 3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders 4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules 5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

What Is The Driver Of The Oral Solid Dosage Contract Manufacturing Market?

The increase in demand for generic drugs is expected to propel the growth of the oral solid dosage contract manufacturing market going forward. Generic drugs are medications that are bioequivalent to brand-name drugs in dosage, strength, safety, performance, quality, and intended use. The rising demand for generic drugs is attributed to patent expirations, cost containment efforts, regulatory incentives, and expanding access to healthcare. Oral solid dosage contract manufacturing significantly aids the production and distribution of generic drugs by leveraging the capabilities of contract manufacturers to enhance their operational efficiency, reduce costs, ensure high-quality production, and bring their products to market more swiftly and effectively. For instance, in 2025, according to the Food and Drug Administration, a US-based federal agency reported that, more than 35,000 generic drugs have been approved by FDA. 9 out of 10 prescriptions are filled with generic drugs. Further, in November of 2024, FDA published over 800 revised PSGs for immediate-release solid oral generic drug products. Therefore, the demand for generic drugs drives the growth of the oral solid dosage contract manufacturing industry.

Key Players In The Global Oral Solid Dosage Contract Manufacturing Market

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Global Oral Solid Dosage Contract Manufacturing Market Trends and Insights

Major companies operating in the oral solid dosage contract manufacturing market are focused on developing innovative solutions, such as continuous manufacturing lines, to sustain their position in the market. A continuous manufacturing line refers to a production facility or system that utilizes continuous manufacturing processes to produce pharmaceuticals or other products. For instance, in January 2023, WuXi STA, a China-based pharmaceutical company, launched its first continuous manufacturing line for oral solid pharmaceutical products. This cutting-edge facility marks a significant advancement in pharmaceutical production, leveraging continuous manufacturing principles to enhance efficiency, quality, and flexibility in drug manufacturing processes. This agility streamlines production timelines and reduces downtime, ultimately accelerating the delivery of vital medications to patients.

What Are Latest Mergers And Acquisitions In The Oral Solid Dosage Contract Manufacturing Market?

In February 2025, Jabil Inc., a US-based provider of engineering, manufacturing, and supply-chain solutions, acquired Pharmaceutics International, Inc. (Pii) for US$ 307 million. Through this acquisition, Jabil aims to strengthen its pharmaceutical manufacturing capabilities, particularly in oral solid dosage forms, by integrating Pii’s contract development and manufacturing services. Pharmaceutics International, Inc. is a US-based CDMO that provides early-stage, clinical, and commercial manufacturing services, including oral solid dose production, aseptic filling, and lyophilization.

Regional Outlook

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oral Solid Dosage Contract Manufacturing Market?

The oral solid dosage contract manufacturing market consists of revenues earned by entities by providing services such as formulation development, analytical and stability testing, and quality assurance and control. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral solid dosage contract manufacturing market also consists of sales of orally disintegrating tablets (ODTS), lozenges, and chewing gums. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oral Solid Dosage Contract Manufacturing Market Report 2026?

The oral solid dosage contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oral solid dosage contract manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.